{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:27:11Z","timestamp":1778812031087,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.diagmicrobio.2013.03.003","type":"journal-article","created":{"date-parts":[[2013,4,8]],"date-time":"2013-04-08T03:31:21Z","timestamp":1365391881000},"page":"182-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Species distribution and drug susceptibilities of Candida isolates in TSARY 2010"],"prefix":"10.1016","volume":"76","author":[{"given":"Yun-Liang","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Chao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Li","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiu-Jung","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0005","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1086\/513663","article-title":"The epidemiology of hematogenous candidiasis caused by different Candida species","volume":"24","author":"Abi-Said","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0010","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/BF01967286","article-title":"Emergence of Candida krusei infections after therapy of oropharyngeal candidiasis with fluconazole","volume":"10","author":"Akova","year":"1991","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0015","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1128\/JCM.43.12.6194-6196.2005","article-title":"PCR protocol for specific identification of Candida nivariensis, a recently described pathogenic yeast","volume":"43","author":"Alcoba-Florez","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0020","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1128\/JCM.43.8.4107-4111.2005","article-title":"del Pilar Arevalo M. Phenotypic and molecular characterization of Candida nivariensis sp. nov., a possible new opportunistic fungus","volume":"43","author":"Alcoba-Florez","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0025","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1128\/JCM.43.4.1829-1835.2005","article-title":"Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003","volume":"43","author":"Almirante","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0030","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1128\/AAC.46.8.2477-2481.2002","volume":"46","author":"Arthington-Skaggs","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0035","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1111\/j.1439-0507.2009.01818.x","article-title":"Species distribution and antifungal susceptibility of blood Candida isolates at a tertiary hospital in southern Taiwan, 1999\u20132006","volume":"54","author":"Chen","year":"2011","journal-title":"Mycoses"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0040","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.3201\/eid1210.060389","article-title":"Active surveillance for candidemia, Australia","volume":"12","author":"Chen","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0045","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2334-5-22","article-title":"Risk factors for fatal candidemia caused by Candida albicans and non-albicans Candida species","volume":"5","author":"Cheng","year":"2005","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.diagmicrobio.2003.08.002","article-title":"Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999","volume":"48","author":"Cheng","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0055","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.diagmicrobio.2007.03.014","article-title":"Multilocus sequence typing of Candida tropicalis shows clonal cluster enriched in isolates with resistance or trailing growth of fluconazole","volume":"58","author":"Chou","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jhin.2010.05.001","article-title":"Secular trends of healthcare-associated infections at a teaching hospital in Taiwan, 1981\u20132007","volume":"76","author":"Chuang","year":"2010","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0065","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard-third edition, M27-S3","author":"Clinical and Laboratory Standards Institute","year":"2008"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0070","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1128\/JCM.00773-06","article-title":"Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers","volume":"44","author":"Colombo","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0075","series-title":"In principles and practice of infectious diseases","first-page":"2289","article-title":"Candida species","author":"Edwards","year":"1995"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0080","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/jac\/dkl555","article-title":"In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest","volume":"59","author":"Fleck","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0085","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s100960000348","article-title":"Epidemiology of yeast colonization in the intensive care unit","volume":"19","author":"Hedderwick","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0090","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s12281-009-0020-z","article-title":"Rare and emerging Candida species","author":"Johnson","year":"2009","journal-title":"Curr Fungal Infect Rep"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0095","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1086\/339946","article-title":"Why prior fluconazole use is associated with an increased risk of invasive mold infections in immunosuppressed hosts: an alternative hypothesis","volume":"34","author":"Kontoyiannis","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0100","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1128\/JCM.00543-07","article-title":"Identification of medically important Candida and non-Candida yeast species by an oligonucleotide array","volume":"45","author":"Leaw","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0105","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/jac\/dkh040","article-title":"Drug resistance genes and trailing growth in Candida albicans isolates","volume":"53","author":"Lee","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0110","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0732-8893(98)00006-6","article-title":"Candida parapsilosis fungemia associated with implantable and semi-implantable central venous catheters and the hands of healthcare workers","volume":"30","author":"Levin","year":"1998","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0115","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1089\/mdr.2009.0915","article-title":"Two closely related fluconazole-resistant Candida tropicalis clones circulating in taiwan from 1999 to 2006","volume":"15","author":"Li","year":"2009","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0120","first-page":"171","article-title":"Factors accounting for mis-identification of Candida species","volume":"34","author":"Lo","year":"2001","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0125","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10096-004-1267-5","article-title":"Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain","volume":"24","author":"Peman","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0135","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.diagmicrobio.2011.03.002","article-title":"Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria","volume":"70","author":"Pfaller","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0140","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.drup.2010.09.002","article-title":"Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods","volume":"13","author":"Pfaller","year":"2010","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0145","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408410903241444","article-title":"Epidemiology of invasive mycoses in North America","volume":"36","author":"Pfaller","year":"2010","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0155","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1128\/JCM.00937-12","article-title":"Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012","volume":"50","author":"Pfaller","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0160","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.drup.2011.01.004","article-title":"Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria","volume":"14","author":"Pfaller","year":"2011","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0165","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1128\/JCM.00248-12","article-title":"Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution","volume":"50","author":"Pfaller","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0170","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/AAC.44.3.747-751.2000","article-title":"Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997\u20131998","volume":"44","author":"Pfaller","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0175","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1128\/JCM.42.7.3142-3146.2004","article-title":"Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002","volume":"42","author":"Pfaller","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0180","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0732-8893(98)00160-6","article-title":"Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States","volume":"33","author":"Pfaller","year":"1999","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"Suppl A","key":"10.1016\/j.diagmicrobio.2013.03.003_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/28.suppl_A.1","article-title":"Opportunistic and pathogenic fungi","volume":"28","author":"Richardson","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0190","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0929-6646(09)60091-7","article-title":"Invasive candidiasis: an overview from Taiwan","volume":"108","author":"Ruan","year":"2009","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0195","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1473-3099(02)00181-0","article-title":"Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences","volume":"2","author":"Sanglard","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0200","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1099\/jmm.0.46664-0","article-title":"Association between fluconazole susceptibility and genetic relatedness among Candida tropicalis isolates in Taiwan","volume":"56","author":"Wang","year":"2007","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3314\/jjmm.48.1","article-title":"Trends in the epidemiology of invasive fungal infections","volume":"48","author":"Warnock","year":"2007","journal-title":"Nippon Ishinkin Gakkai Zasshi"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0210","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/CMR.11.2.382","article-title":"Clinical, cellular, and molecular factors that contribute to antifungal drug resistance","volume":"11","author":"White","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0215","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study","volume":"39","author":"Wisplinghoff","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0220","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/13693780500401213","article-title":"Distribution and antifungal susceptibility of Candida species isolated from different age populations in Taiwan","volume":"44","author":"Yang","year":"2006","journal-title":"Med Mycol"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0225","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3109\/13693780903154070","article-title":"The distribution of species and susceptibility of amphotericin B and fluconazole of yeast pathogens isolated from sterile sites in Taiwan","volume":"48","author":"Yang","year":"2010","journal-title":"Med Mycol"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0230","article-title":"An emerging issue of mixed yeast cultures","author":"Yang","year":"2013","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0235","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1086\/502294","article-title":"Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis","volume":"25","author":"Yang","year":"2004","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0240","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11046-011-9408-8","article-title":"Characterization of Candida Species from Different Populations in Taiwan","volume":"172","author":"Yang","year":"2011","journal-title":"Mycopathologia"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0245","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.diagmicrobio.2004.11.004","article-title":"Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002","volume":"51","author":"Yang","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0250","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1471-2334-5-99","article-title":"The trend of susceptibilities to amphotericin B and fluconazole of Candida species from 1999 to 2002 in Taiwan","volume":"5","author":"Yang","year":"2005","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0255","doi-asserted-by":"crossref","first-page":"e34609","DOI":"10.1371\/journal.pone.0034609","article-title":"Comparison of human and soil Candida tropicalis isolates with reduced susceptibility to fluconazole","volume":"7","author":"Yang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0260","first-page":"79","article-title":"Mechanisms of antifungal agent resistance","volume":"34","author":"Yang","year":"2001","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.diagmicrobio.2013.03.003_bb0265","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.diagmicrobio.2008.01.011","article-title":"Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2006","volume":"61","author":"Yang","year":"2008","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889313001363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889313001363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:51:19Z","timestamp":1760003479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889313001363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0732889313001363"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2013.03.003","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Species distribution and drug susceptibilities of Candida isolates in TSARY 2010","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2013.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}